Company Filing History:
8 out of 1,168 
2 out of 64 
1 out of 155 
Years Active: 2004-2022
Title: The Innovative Contributions of Moshe Oren
Introduction
Moshe Oren is a prominent inventor based in Rehovot, Israel, known for his significant contributions to the field of biotechnology. With a total of nine patents to his name, Oren has focused on developing innovative solutions for medical challenges, particularly those related to mutant p53 proteins.
Latest Patents
Oren's latest patents include groundbreaking work on peptides and their use in treating diseases associated with mutant p53. One notable patent describes an isolated peptide that interacts with the DNA Binding Domain (DBD) of p53, facilitating the reactivation of mutant p53 proteins. This peptide is designed to restore the tumor suppressor activity of p53, which is crucial for combating various conditions where p53 is mutated. Another patent highlights peptides capable of efficiently reactivating p53 mutants, along with methods for identifying and isolating these peptides in a cost-effective manner.
Career Highlights
Throughout his career, Moshe Oren has worked with esteemed organizations such as Yeda Research and Development Company and Rosetta Genomics. His work has significantly advanced the understanding of p53 mutations and their implications in cancer treatment.
Collaborations
Oren has collaborated with notable colleagues, including Varda Rotter and Perry Tal, contributing to a rich exchange of ideas and innovations in the field of biotechnology.
Conclusion
Moshe Oren's innovative work in developing peptides for the treatment of diseases associated with mutant p53 proteins showcases his dedication to advancing medical science. His contributions continue to have a lasting impact on the field of biotechnology and cancer research.